Organigram Global (OGI) Invested Capital (2018 - 2024)
Organigram Global (OGI) posted quarterly Invested Capital of $18326.3 for Q3 2024, down 84.15% year-on-year from $115619.2 in Q4 2023, and down 84.15% on a QoQ basis from $115619.2 in Q3 2023.
Organigram Global (OGI) Invested Capital (2018 - 2024) Analysis & Trends
Organigram Global (OGI) has reported Invested Capital for 7 consecutive years, with $18326.3 the latest figure, recorded in Q3 2024.
- Quarterly Invested Capital fell 84.15% year-over-year to $18326.3 in Q3 2024, while the trailing twelve-month figure through Mar 2026 was $0.0 (down 100.0% YoY) and the FY2024 annual result came in at $18326.3, down 84.06% from the prior year.
- Invested Capital retreated to $18326.3 in Q3 2024 per OGI's latest filing, from $115619.2 in the prior quarter.
- Over the last five years, Invested Capital for OGI reached as high as $85.8 million in Q3 2020 and fell as low as $18326.3 in Q3 2024.
- A 5-year average of $22.1 million and a median of $249384.2 in 2021 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2020 — Invested Capital surged 128.75% — and 2021, when it slumped 99.87%.
- Year by year, Invested Capital stood at $61.1 million in 2020, then sank by 99.87% to $80000.0 in 2021, then surged by 128.1% to $182481.7 in 2022, then tumbled by 36.64% to $115619.2 in 2023, then tumbled by 84.15% to $18326.3 in 2024.
- According to Business Quant data, Invested Capital over the past three periods registered $18326.3, $115619.2, and $182481.7 for Q3 2024, Q3 2023, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18,326.34 |
| Sep 30, 2023 | 115,619.22 |
| Aug 31, 2022 | 182,481.74 |
| Nov 30, 2021 | 80,000.00 |
| Aug 31, 2021 | 249,384.18 |
| May 31, 2021 | 80,000.00 |
| Feb 28, 2021 | 6.05 Mn |
| Nov 30, 2020 | 61.15 Mn |
| Aug 31, 2020 | 85.78 Mn |
| May 31, 2020 | 4.69 Mn |
| Feb 29, 2020 | 84.91 Mn |
| Aug 31, 2019 | 37.50 Mn |
| Aug 31, 2018 | 2.52 Mn |